[VRDN] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
29-Sep-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -62.96%
YoY-
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 1,301 1,274 1,091 1,091 984 1,103 1,139 9.26%
PBT -1,637 -3,289 -706 -203 -880 -540 -537 110.09%
Tax 0 0 0 0 0 0 0 -
NP -1,637 -3,289 -706 -203 -880 -540 -537 110.09%
Tax Rate - - - - - - - -
Total Cost 2,938 4,563 1,797 1,294 1,863 1,643 1,677 45.27%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin -125.84 -258.25 -64.70 -18.63 -89.43 -48.93 -47.14 92.32%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -6.05 -12.14 -2.80 -1.08 -4.68 -2.87 -2.86 64.71%
EPS Diluted -6.05 -12.14 -2.80 -1.08 -4.68 -2.87 -2.86 64.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.